Clinical trial
Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia
NCT00006097 · Boston Medical Center, Other · Completed
Key facts
| NCT number | NCT00006097 |
|---|---|
| Title | Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia |
| Official title | CC-1088 Therapy for Chronic Lymphocytic Leukemia: A Phase I/II Trial |
| Lead sponsor | Boston Medical Center, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug |
| Interventions | CC-1088 |
| Start date | Aug 1, 1999 |
| Primary completion | Jul 1, 2005 |
| Completion | Jul 1, 2005 |
| First posted | May 4, 2004 |
| Last update posted | Sep 22, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: